Clinical Report: Identifying Biomarkers to Distinguish Diabetic Periodontitis
Overview
This systematic review and meta-analysis identified significant biomarkers that differentiate diabetic periodontitis (DMCP) from chronic periodontitis (CP). Key findings include elevated levels of very low-density lipoprotein (VLDL), interleukin-8 (IL-8), and high-sensitivity C-reactive protein (hs-CRP) in DMCP patients compared to those with CP.
Background
Diabetes-related periodontitis and chronic periodontitis exhibit notable differences in clinical presentation and treatment outcomes. Identifying reliable biomarkers for early differentiation is crucial for improving clinical management and patient outcomes. Understanding these differences can enhance the approach to treatment and monitoring in patients with diabetes.
Data Highlights
Biomarker
DMCP Level
CP Level
SMD (95% CI)
P-value
VLDL
Higher
Lower
0.91 (0.43 to 1.39)
<0.001
IL-8
Higher
Lower
0.38 (0.06 to 0.70)
0.021
hs-CRP
Higher
Lower
2.56 (0.31 to 4.82)
0.026
CAT
Lower
Higher
-0.31 (-0.58 to -0.05)
0.021
GSSG
Lower
Higher
-1.16 (-1.76 to -0.55)
<0.001
NOS
Higher
Lower
0.58 (0.11 to 1.05)
0.016
4-HNE
Higher
Lower
7.05 (5.07 to 9.03)
<0.001
Key Findings
DMCP patients showed significantly higher levels of VLDL compared to CP patients.
Elevated levels of IL-8 and hs-CRP were found in the DMCP group.
DMCP patients had lower levels of catalase (CAT) and oxidized glutathione (GSSG).
Higher levels of nitric oxide synthase (NOS) and 4-hydroxynonenal (4-HNE) were observed in DMCP patients.
Other biomarkers such as body mass index and eotaxin were significantly elevated in the DMCP group.
Clinical Implications
The identification of specific biomarkers can aid in the early differentiation of diabetic periodontitis from chronic periodontitis, potentially leading to tailored treatment strategies. Clinicians should consider these biomarkers when assessing patients with diabetes and periodontal disease.
Conclusion
This study highlights significant biomarker differences between DMCP and CP, emphasizing the need for further research to refine diagnostic and treatment approaches in affected patients.
